The George Washington University School of Medicine and Health Sciences is one of only two sites chosen for the first clinical trial of the eOD-GT8 60mer HIV vaccine candidate. Read more about the specifics of this study in this article!
GW Serving as Site for HIV Vaccine Trial
Latest News
Dr. David Diemert, the director of the George Washington University Vaccine Research Unit, weighs in on President Donald Trump's executive order pushing for revisions to how children in the US are vaccinated and what that means for the future.
The GW VRU is a site for a clinical trial to examine Pfizer's new C. diff vaccine.
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.
